{"transactions":[{"id":1660936,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Stock Option (Right to buy)","published_at":"2024-02-02T21:10:57.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":224000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":224000,"derivative":{"exercise_price":1.68,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":224000},"source":{"system":"sec-edgar","filing":"0001562180-24-000975","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218024000975/primarydocument.xml","form_type":"4"}},{"id":1660935,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2024-02-02T21:10:57.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":149300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan.   One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":519300,"source":{"system":"sec-edgar","filing":"0001562180-24-000975","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218024000975/primarydocument.xml","form_type":"4"}},{"id":1818976,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-08-01T20:35:24.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":560000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted by the Issuer as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4).  The options will vest over four years:  25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":560000,"derivative":{"exercise_price":1.67,"expiration_date":"2033-07-31","underlying":"Common Stock","underlying_shares":560000},"source":{"system":"sec-edgar","filing":"0001562180-23-006088","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218023006088/primarydocument.xml","form_type":"4"}},{"id":1818975,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2023-08-01T20:35:24.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":370000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan.  One third of the RSUs will vest upon each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":370000,"source":{"system":"sec-edgar","filing":"0001562180-23-006088","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218023006088/primarydocument.xml","form_type":"4"}},{"id":2006295,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-17T16:14:54.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of PEAR Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026."}],"balance_after":40000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001062993-23-004045","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1786643/000106299323004045/form4.xml","form_type":"4"}},{"id":2006294,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-17T16:14:54.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":199864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of PEAR Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026."}],"balance_after":199864,"derivative":{"underlying":"Class A Common Stock","underlying_shares":199864},"source":{"system":"sec-edgar","filing":"0001062993-23-004045","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786643/000106299323004045/form4.xml","form_type":"4"}},{"id":2047193,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2023-01-24T16:08:49.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":8027,"price":1.13,"value":9070.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.03 to $1.335, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4."}],"balance_after":23318,"source":{"system":"sec-edgar","filing":"0001062993-23-001326","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786643/000106299323001326/form4.xml","form_type":"4"}},{"id":2051958,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-18T17:02:54.000Z","date":"2023-01-14","kind":"exercise","acquired":false,"shares":20320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of PEAR common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025."}],"balance_after":41256,"derivative":{"underlying":"Common Stock","underlying_shares":20320},"source":{"system":"sec-edgar","filing":"0001062993-23-001037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1786643/000106299323001037/form4.xml","form_type":"4"}},{"id":2051957,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-01-18T17:02:54.000Z","date":"2023-01-14","kind":"exercise","acquired":true,"shares":20320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 11,025 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 30, 2022."}],"balance_after":31345,"source":{"system":"sec-edgar","filing":"0001062993-23-001037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786643/000106299323001037/form4.xml","form_type":"4"}},{"id":2384651,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-18T16:45:40.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":61576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of PEAR common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest and settle as to 33% of the shares on January 14, 2023, 33% of the shares on January 14, 2024 and the final 34% on January 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest and settle as to 33% of the shares on January 14, 2023, 33% of the shares on January 14, 2024 and the final 34% on January 14, 2025."}],"balance_after":61576,"derivative":{"underlying":"Common Stock","underlying_shares":61576},"source":{"system":"sec-edgar","filing":"0001062993-22-004988","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786643/000106299322004988/form4.xml","form_type":"4"}},{"id":2481644,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-07T17:26:40.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":265034,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in accordance with the terms of the Business Combination Agreement (the \"Business Combination Agreement\") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) (\"Private Pear\"), in exchange for an option to acquire 180,000 shares of common stock of Private Pear for $2.06 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vested or shall vest on March 29, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter."}],"balance_after":265034,"derivative":{"exercise_price":1.4,"expiration_date":"2031-04-28","underlying":"Common Stock","underlying_shares":265034},"source":{"system":"sec-edgar","filing":"0001062993-21-012401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1786643/000106299321012401/form4.xml","form_type":"4"}},{"id":2942938,"issuer":{"id":115386,"kind":"organization","name":"AlerisLife Inc.","symbol":"ALR"},"owners":[{"id":94658,"kind":"person","name":"Snow Ellen","position":1,"cik":"0001786643","reported_name":"Snow Ellen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2020-12-16T16:16:30.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Transaction reported is grant of shares pursuant to issuer's equity compensation plan."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-20-136291","document":"tm2038461-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159281/000110465920136291/tm2038461-4_4seq1.xml","form_type":"4"}}]}